Epilepsy Surgery in Antibody-Associated Autoimmune Encephalitis and Epilepsies: Review of Literature

Abstract

There is lack of studies that explore the role of epilepsy surgery in the treatment of drug-refractory antibody-associated autoimmune encephalitis and epilepsies. Some case reports and series suggest that surgical treatment may still be an option, but compared with other etiologies, its surgical outcome seems to be less favorable. The following review summarizes the existing experience on the surgical treatment of drug-refractory seizures associated with antibody-associated autoimmune encephalitis and epilepsies.

Keywords

autoantibody - encephalitis - surgery

• References

• 1 Iffland II PH, Carvalho-Tavares J, Trigunaite A. , et al. Intracellular and circulating neuronal antinuclear antibodies in human epilepsy. Neurobiol Dis 2013; 59: 206-219
• 2 Dalmau J, Tüzün E, Wu HY. , et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007; 61 (01) 25-36
• 3 Irani SR, Michell AW, Lang B. , et al. Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis. Ann Neurol 2011; 69 (05) 892-900
• 4 Lancaster E, Lai M, Peng X. , et al. Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol 2010; 9 (01) 67-76
• 5 Lai M, Hughes EG, Peng X. , et al. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol 2009; 65 (04) 424-434
• 6 Suleiman J, Dale RC. The recognition and treatment of autoimmune epilepsy in children. Dev Med Child Neurol 2015; 57 (05) 431-440
• 7 Dubey D, Alqallaf A, Hays R. , et al. Neurological autoantibody prevalence in epilepsy of unknown etiology. JAMA Neurol 2017; 74 (04) 397-402
• 8 Scheffer IE, Berkovic S, Capovilla G. , et al. ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology. Epilepsia 2017; 58 (04) 512-521
• 9 Lancaster E, Martinez-Hernandez E, Dalmau J. Encephalitis and antibodies to synaptic and neuronal cell surface proteins. Neurology 2011; 77 (02) 179-189
• 10 Bien CG, Bauer J. Autoimmune epilepsies. Neurotherapeutics 2014; 11 (02) 311-318
• 11 Dalmau J, Gleichman AJ, Hughes EG. , et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008; 7 (12) 1091-1098
• 12 Bastiaansen AEM, van Sonderen A, Titulaer MJ. Autoimmune encephalitis with anti-leucine-rich glioma-inactivated 1 or anti-contactin-associated protein-like 2 antibodies (formerly called voltage-gated potassium channel-complex antibodies). Curr Opin Neurol 2017; 30 (03) 302-309
• 13 Herranz-Pérez V, Olucha-Bordonau FE, Morante-Redolat JM, Pérez-Tur J. Regional distribution of the leucine-rich glioma inactivated (LGI) gene family transcripts in the adult mouse brain. Brain Res 2010; 1307: 177-194
• 14 Fukata Y, Adesnik H, Iwanaga T, Bredt DS, Nicoll RA, Fukata M. Epilepsy-related ligand/receptor complex LGI1 and ADAM22 regulate synaptic transmission. Science 2006; 313 (5794): 1792-1795
• 15 Ohkawa T, Fukata Y, Yamasaki M. , et al. Autoantibodies to epilepsy-related LGI1 in limbic encephalitis neutralize LGI1-ADAM22 interaction and reduce synaptic AMPA receptors. J Neurosci 2013; 33 (46) 18161-18174
• 16 Britton J. Autoimmune epilepsy. Handb Clin Neurol 2016; 133: 219-245
• 17 Byun JI, Lee ST, Jung KH. , et al. Effect of immunotherapy on seizure outcome in patients with autoimmune encephalitis: a prospective observational registry study. PLoS One 2016; 11 (01) e0146455
• 18 Urbach H, Soeder BM, Jeub M, Klockgether T, Meyer B, Bien CG. Serial MRI of limbic encephalitis. Neuroradiology 2006; 48 (06) 380-386
• 19 Kotsenas AL, Watson RE, Pittock SJ. , et al. MRI findings in autoimmune voltage-gated potassium channel complex encephalitis with seizures: one potential etiology for mesial temporal sclerosis. Am J Neuroradiol 2014; 35 (01) 84-89
• 20 Carreño M, Bien CG, Asadi-Pooya AA. , et al. Epilepsy surgery in drug resistant temporal lobe epilepsy associated with neuronal antibodies. Epilepsy Res 2017; 129: 101-105
• 21 Gagnon MM, Savard M, Mourabit Amari K. Refractory status epilepticus and autoimmune encephalitis with GABAAR and GAD65 antibodies: a case report. Seizure 2016; 37: 25-27
• 22 Petit-Pedrol M, Armangue T, Peng X. , et al. Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies. Lancet Neurol 2014; 13 (03) 276-286
• 23 Kirkpatrick MP, Clarke CD, Sonmezturk HH, Abou-Khalil B. Rhythmic delta activity represents a form of nonconvulsive status epilepticus in anti-NMDA receptor antibody encephalitis. Epilepsy Behav 2011; 20 (02) 392-394
• 24 Johnson N, Henry C, Fessler AJ, Dalmau J. Anti-NMDA receptor encephalitis causing prolonged nonconvulsive status epilepticus. Neurology 2010; 75 (16) 1480-1482
• 25 Ilyas M, Sivaswamy L, Asano E, Sood S, Zidan M, Chugani H. Seizure control following palliative resective surgery for intractable epilepsy-a pilot study. Pediatr Neurol 2014; 51 (03) 330-335
• 26 Kumar A, Chugani HT, Luat A, Asano E, Sood S. Epilepsy surgery in a case of encephalitis: use of 11C-PK11195 positron emission tomography. Pediatr Neurol 2008; 38 (06) 439-442
• 27 Barros P, Brito H, Ferreira PC. , et al. Resective surgery in the treatment of super-refractory partial status epilepticus secondary to NMDAR antibody encephalitis. Eur J Paediatr Neurol 2014; 18 (03) 449-452
• 28 Muehlebner A, Groeppel G, Pahs G. , et al. Beneficial effect of epilepsy surgery in a case of childhood non-paraneoplastic limbic encephalitis. Epilepsy Res 2010; 90 (03) 295-299
• 29 Sato Y, Numata-Uematsu Y, Uematsu M. , et al. Acute encephalitis with refractory, repetitive partial seizures: Pathological findings and a new therapeutic approach using tacrolimus. Brain Dev 2016; 38 (08) 772-776
• 30 Almeida V, Pimentel J, Campos A. , et al. Surgical control of limbic encephalitis associated with LGI1 antibodies. Epileptic Disord 2012; 14 (03) 345-348
• 31 Weimer T, Boling W, Pryputniewicz D, Palade A. Temporal lobectomy for refractory status epilepticus in a case of limbic encephalitis. J Neurosurg 2008; 109 (04) 742-745
• 32 Bick SK, Izzy S, Rubin DB, Zafar SF, Rosenthal ES, Eskandar EN. Anterior temporal lobectomy for refractory status epilepticus in herpes simplex encephalitis. Neurocrit Care 2016; 25 (03) 458-463
• 33 Malter MP, Frisch C, Zeitler H. , et al. Treatment of immune-mediated temporal lobe epilepsy with GAD antibodies. Seizure 2015; 30: 57-63
• 34 Quek AM, Britton JW, McKeon A. , et al. Autoimmune epilepsy: clinical characteristics and response to immunotherapy. Arch Neurol 2012; 69 (05) 582-593
• 35 Glover RL, DeNiro LV, Lasala PA, Weidenheim KM, Graber JJ, Boro A. ILAE type 3 hippocampal sclerosis in patients with anti-GAD-related epilepsy. Neurol Neuroimmunol Neuroinflamm 2015; 2 (04) e122
• 36 Vanli-Yavuz EN, Erdag E, Tuzun E. , et al. Neuronal autoantibodies in mesial temporal lobe epilepsy with hippocampal sclerosis. J Neurol Neurosurg Psychiatry 2016; 87 (07) 684-692
• 37 Kerling F, Blümcke I, Stefan H. Pitfalls in diagnosing limbic encephalitis - a case report. Acta Neurol Scand 2008; 118 (05) 339-342
• 38 Yamazoe T, Okanishi T, Yamamoto A. , et al. New-onset refractory status epilepticus treated with vagus nerve stimulation: a case report. Seizure 2017; 47: 1-4
• 39 Alsaadi T, Shakra M, Turkawi L, Hamid J. VNS terminating refractory nonconvulsive SE secondary to anti-NMDA encephalitis: a case report. Epilepsy Behav Case Rep 2015; 3: 39-42
• 40 Mathon B, Bédos Ulvin L, Adam C. , et al. Surgical treatment for mesial temporal lobe epilepsy associated with hippocampal sclerosis. Rev Neurol (Paris) 2015; 171 (03) 315-325
• 41 Patwardhan RV, Dellabadia Jr J, Rashidi M, Grier L, Nanda A. Control of refractory status epilepticus precipitated by anticonvulsant withdrawal using left vagal nerve stimulation: a case report. Surg Neurol 2005; 64 (02) 170-173
• 42 O'Neill BR, Valeriano J, Synowiec A, Thielmann D, Lane C, Wilberger J. Refractory status epilepticus treated with vagal nerve stimulation: case report. Neurosurgery 2011; 69 (05) E1172-E1175
• 43 Sierra-Marcos A, Maestro I, Rodríguez-Osorio X. , et al. Successful outcome of episodes of status epilepticus after vagus nerve stimulation: a multicenter study. Eur J Neurol 2012; 19 (09) 1219-1223
• 44 De Herdt V, Waterschoot L, Vonck K. , et al. Vagus nerve stimulation for refractory status epilepticus. Eur J Paediatr Neurol 2009; 13 (03) 286-289
• 45 Winston KR, Levisohn P, Miller BR, Freeman J. Vagal nerve stimulation for status epilepticus. Pediatr Neurosurg 2001; 34 (04) 190-192
• 46 De Herdt V, Bogaert S, Bracke KR. , et al. Effects of vagus nerve stimulation on pro- and anti-inflammatory cytokine induction in patients with refractory epilepsy. J Neuroimmunol 2009; 214 (1–2): 104-108
• 47 Aalbers MW, Klinkenberg S, Rijkers K. , et al. The effects of vagus nerve stimulation on pro- and anti-inflammatory cytokines in children with refractory epilepsy: an exploratory study. Neuroimmunomodulation 2012; 19 (06) 352-358
• 48 Bhatia S, Schmitt SE. Treating immune-related epilepsy. Curr Neurol Neurosci Rep 2018; 18 (03) 10